CW
ABBV icon

CIC Wealth’s AbbVie ABBV Stock Holding History

CIC Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.32M Sell
6,689
-24
-0.4% -$4.48K 0.34% 64
2024
Q2 		$1.15M Sell
6,713
-84
-1% -$13.9K 0.32% 63
2024
Q1 		$1.24M Buy
6,797
+923
+16% +$159K 0.36% 65
2023
Q4 		$910K Buy
5,874
+1,197
+26% +$175K 0.29% 70
2023
Q3 		$697K Buy
4,677
+14
+0.3% +$2.06K 0.25% 78
2023
Q2 		$628K Sell
4,663
-499
-10% -$73.2K 0.22% 85
2023
Q1 		$823K Hold
5,162
– – 0.31% 68
2022
Q4 		$834K Buy
+5,162
New +$792K 0.34% 63

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

CIC Wealth's ABBV Position: Q3 2024 in Review

CIC Wealth reduced its AbbVie (ABBV) stake by 0.36% in Q3 2024, selling an estimated $4.48K and leaving 6,689 shares worth $1.32M. The position accounts for 0.34% of the portfolio, ranked #64.

CIC Wealth first reported a position in ABBV in Q4 2022 and has held it in 8 quarters since. 3,504 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • CIC Wealth held 6,689 shares of AbbVie worth $1.32M as of Q3 2024.
  • CIC Wealth sold 24 AbbVie shares in Q3 2024, an estimated $4.48K.
  • AbbVie made up 0.34% of CIC Wealth's portfolio in Q3 2024, its #64 holding.
  • CIC Wealth first reported a position in AbbVie in Q4 2022 and has held it in 8 quarters since.
  • 3,504 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on CIC Wealth's 13F filing for Q3 2024, filed 8 Nov 2024.